Tyler V. Schrand

ORCID: 0009-0007-7283-4951
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Radiomics and Machine Learning in Medical Imaging
  • Advanced Radiotherapy Techniques
  • Glioma Diagnosis and Treatment
  • Head and Neck Cancer Studies
  • BRCA gene mutations in cancer
  • Brain Metastases and Treatment
  • Breast Lesions and Carcinomas
  • Artificial Intelligence in Healthcare and Education
  • Mesoporous Materials and Catalysis
  • Dysphagia Assessment and Management
  • Oral health in cancer treatment
  • Management of metastatic bone disease
  • Silicone and Siloxane Chemistry
  • Breast Cancer Treatment Studies
  • Polyoxometalates: Synthesis and Applications
  • Meningioma and schwannoma management
  • Lung Cancer Diagnosis and Treatment

Tulane University
2024-2025

Roswell Park Comprehensive Cancer Center
2024-2025

Bowling Green State University
2022-2024

Radiation oncology relies on computer software for digital processing and planning. Artificial intelligence (AI) employs algorithms to perform tasks including pattern recognition, decision making problem solving [1]. AI has the potential impact quality of radiotherapy cancer patients [2].

10.1016/j.adro.2024.101505 article EN cc-by Advances in Radiation Oncology 2024-04-16

Octa(dimethylsiloxy)silica cages (Q8M8H) undergo rapid self-polymerization in the presence of a fluoride catalyst to form complex 3D porous structural network materials with specific surface areas up 650 m2 g-1. This establishes new method bio-derived high inorganic content soft silicas potential applications filtration, carbon capture, catalysis, or hydrogen source.

10.1039/d2cc02672d article EN Chemical Communications 2022-01-01

We investigated the survival and patterns of failure in adenocarcinoma (ADC) squamous cell carcinoma (SCC) early stage non-small lung cancer (NSCLC) treated with single-fraction stereotactic body radiation therapy (SF-SBRT) 27–34 Gray. A single-institution retrospective review patients biopsy-proven ADC or SCC undergoing definitive SF-SBRT between September 2008 February 2023 was performed. The primary outcomes were overall (OS) disease-free (DFS). secondary included local (LF), nodal (NF),...

10.3390/cancers16040755 article EN Cancers 2024-02-12
Coming Soon ...